
95% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
ORIGINAL RESEARCH article
Front. Oncol. , 20 July 2020
Sec. Gastrointestinal Cancers
Volume 10 - 2020 | https://doi.org/10.3389/fonc.2020.01044
This article is part of the Research Topic Novel Molecular Targets and Treatments for Gastroesophageal Cancer View all 26 articles
A retraction of this article was approved in:
Retraction: RBFOX3 Promotes Gastric Cancer Growth and Progression by Activating HTERT Signaling
Citation: Luo C, Zhu X, Luo Q, Bu F, Huang C, Zhu J, Zhao J, Zhang W, Lin K, Hu C, Zong Z, Luo H, Huang J and Zhu Z (2020) RBFOX3 Promotes Gastric Cancer Growth and Progression by Activating HTERT Signaling. Front. Oncol. 10:1044. doi: 10.3389/fonc.2020.01044
Received: 13 April 2020; Accepted: 26 May 2020;
Published: 20 July 2020; Retracted: 31 August 2021.
Edited by:
Wen Wen Xu, Jinan University, ChinaDisclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.